Objectives: Cancer survival rates vary widely between European countries, with differences in timeliness of diagnosis thought to be one key reason. There is little evidence on the way in which different healthcare systems influence primary care practitioners' (PCPs) referral decisions in patients who could have cancer.This study aimed to explore PCPs' diagnostic actions (whether or not they perform a key diagnostic test and/or refer to a specialist) in patients with symptoms that could be due to cancer and how they vary across European countries. Design: A primary care survey. PCPs were given vignettes describing patients with symptoms that could indicate cancer and asked how they would manage these patients. The likelihood of taking immedi...
Objectives Cancer survival and stage of disease at diagnosis and treatment vary widely across Europe...
Objectives Cancer survival and stage of disease at diagnosis and treatment vary widely across Europe...
Objectives Cancer survival and stage of disease at diagnosis and treatment vary widely across Europe...
Objectives: Cancer survival rates vary widely between European countries, with differences in timeli...
OBJECTIVES: Cancer survival rates vary widely between European countries, with differences in timeli...
OBJECTIVES: Cancer survival rates vary widely between European countries, with differences in timeli...
OBJECTIVES: Cancer survival rates vary widely between European countries, with differences in timeli...
Objectives Cancer survival rates vary widely between European countries, with differences in timelin...
Objectives Cancer survival rates vary widely between European countries, with differences in timelin...
Objectives Cancer survival rates vary widely between European countries, with differences in timelin...
Objectives Cancer survival rates vary widely between European countries, with differences in timelin...
OBJECTIVES Cancer survival rates vary widely between European countries, with differences in time...
Abstract Background Diagnosing cancer at an early stage increases the likelihood of survival, and mo...
Objectives Cancer survival and stage of disease at diagnosis and treatment vary widely across Europe...
OBJECTIVES: Cancer survival and stage of disease at diagnosis and treatment vary widely across Europ...
Objectives Cancer survival and stage of disease at diagnosis and treatment vary widely across Europe...
Objectives Cancer survival and stage of disease at diagnosis and treatment vary widely across Europe...
Objectives Cancer survival and stage of disease at diagnosis and treatment vary widely across Europe...
Objectives: Cancer survival rates vary widely between European countries, with differences in timeli...
OBJECTIVES: Cancer survival rates vary widely between European countries, with differences in timeli...
OBJECTIVES: Cancer survival rates vary widely between European countries, with differences in timeli...
OBJECTIVES: Cancer survival rates vary widely between European countries, with differences in timeli...
Objectives Cancer survival rates vary widely between European countries, with differences in timelin...
Objectives Cancer survival rates vary widely between European countries, with differences in timelin...
Objectives Cancer survival rates vary widely between European countries, with differences in timelin...
Objectives Cancer survival rates vary widely between European countries, with differences in timelin...
OBJECTIVES Cancer survival rates vary widely between European countries, with differences in time...
Abstract Background Diagnosing cancer at an early stage increases the likelihood of survival, and mo...
Objectives Cancer survival and stage of disease at diagnosis and treatment vary widely across Europe...
OBJECTIVES: Cancer survival and stage of disease at diagnosis and treatment vary widely across Europ...
Objectives Cancer survival and stage of disease at diagnosis and treatment vary widely across Europe...
Objectives Cancer survival and stage of disease at diagnosis and treatment vary widely across Europe...
Objectives Cancer survival and stage of disease at diagnosis and treatment vary widely across Europe...